Federated Hermes, Inc. Supernus Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$52.5 Billion
Q3 2025

A detailed history of Federated Hermes, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,546 shares of SUPN stock, worth $114,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,546

Previous 1,572 61.96%

Holding current value

$114,570

Previous $49,000 146.94%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$31.45 - $47.79 $30,632 - $46,547	974 Added 61.96%	2,546 $121,000
Q2 2025 Aug 13, 2025	SELL	$30.29 - $33.43 $393 - $434	-13 Reduced 0.82%	1,572 $49,000
Q1 2025 May 08, 2025	SELL	$31.17 - $40.0 $654 - $840	-21 Reduced 1.31%	1,585 $51,000
Q4 2024 Feb 13, 2025	SELL	$31.89 - $37.83 $1.29 Million - $1.53 Million	-40,453 Reduced 96.18%	1,606 $58,000
Q3 2024 Nov 13, 2024	SELL	$25.77 - $35.16 $104,858 - $143,066	-4,069 Reduced 8.82%	42,059 $1.31 Million

Q2 2024 Aug 08, 2024	SELL	$25.99 - $33.85 $3,950 - $5,145	-152 Reduced 0.33%	46,128 $1.23 Million
Q1 2024 May 14, 2024	SELL	$27.11 - $35.17 $103,045 - $133,681	-3,801 Reduced 7.59%	46,280 $1.58 Million
Q4 2023 Jan 31, 2024	SELL	$22.72 - $29.68 $331,371 - $432,882	-14,585 Reduced 22.55%	50,081 $1.45 Million
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $269,524 - $321,728	9,776 Added 17.81%	64,666 $1.78 Million
Q2 2023 Aug 14, 2023	SELL	$29.91 - $38.73 $814,479 - $1.05 Million	-27,231 Reduced 33.16%	54,890 $1.65 Million
Q1 2023 May 08, 2023	BUY	$34.93 - $42.03 $1.68 Million - $2.02 Million	48,005 Added 140.71%	82,121 $2.98 Million
Q4 2022 Feb 13, 2023	SELL	$31.09 - $37.88 $41,256 - $50,266	-1,327 Reduced 3.74%	34,116 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $1.02 Million - $1.25 Million	35,319 Added 28483.06%	35,443 $1.2 Million
Q2 2022 Aug 15, 2022	SELL	$25.33 - $34.25 $3.2 Million - $4.32 Million	-126,206 Reduced 99.9%	124 $4,000
Q1 2022 May 13, 2022	SELL	$28.51 - $32.9 $167,154 - $192,892	-5,863 Reduced 4.44%	126,330 $4.08 Million
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $3.49 Million - $4.52 Million	132,193 New	132,193 $3.86 Million
Q2 2021 Aug 16, 2021	SELL	$26.72 - $33.19 $5.24 Million - $6.5 Million	-195,947 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$24.15 - $31.45 $349,692 - $455,396	14,480 Added 7.98%	195,947 $5.13 Million
Q4 2020 Feb 12, 2021	BUY	$17.7 - $25.81 $902 - $1,316	51 Added 0.03%	181,467 $4.57 Million
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $2.69 Million - $3.34 Million	133,255 Added 276.69%	181,416 $3.78 Million
Q2 2020 Aug 13, 2020	BUY	$17.09 - $24.89 $823,071 - $1.2 Million	48,161 New	48,161 $1.14 Million
Q1 2020 May 13, 2020	SELL	$14.45 - $24.69 $2.82 Million - $4.82 Million	-195,025 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$19.93 - $29.13 $1.73 Million - $2.52 Million	-86,642 Reduced 30.76%	195,025 $4.63 Million
Q3 2019 Nov 14, 2019	BUY	$25.47 - $33.37 $3.36 Million - $4.4 Million	131,935 Added 88.11%	281,667 $7.74 Million
Q2 2019 Aug 14, 2019	BUY	$29.96 - $38.87 $3.59 Million - $4.66 Million	119,974 Added 403.17%	149,732 $4.96 Million
Q1 2019 May 10, 2019	BUY	$32.77 - $41.99 $975,169 - $1.25 Million	29,758 New	29,758 $1.04 Million
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $7.2 Million - $9.54 Million	-168,735 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$44.1 - $59.85 $6.08 Million - $8.25 Million	137,909 Added 447.38%	168,735 $10.1 Million
Q1 2018 May 09, 2018	BUY	$37.15 - $46.9 $1.09 Million - $1.37 Million	29,299 Added 1918.73%	30,826 $1.41 Million
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $1.01 Million - $1.18 Million	-27,711 Reduced 94.78%	1,527 $0
Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $1.07 Million - $1.45 Million	29,238	29,238 $1.17 Million

Others Institutions Holding SUPN

# of Institutions

330

Shares Held

60.2M

Call Options Held

234K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.41B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Supernus Pharmaceuticals, Inc. Transaction History